Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."

17:49 26/11/2025

Tide Pharmaceutical (000590.SZ) announced that the Board of Directors has approved the proposal to change the company's name to "Guhan Pharmaceutical Group Co., Ltd." and to revise the company's articles of association. After the company name change is completed, the company will apply to the Shenzhen Stock Exchange for a change in its stock abbreviation in accordance with relevant regulations.

Tus-Pharmaceutical Group (000590.SZ) announced that the board of directors has approved the proposal to change the company's name to "Guhan Pharmaceutical Group Co., Ltd." and to revise the company's Articles of Association. After the name change is completed, the company will apply to the Shenzhen Stock Exchange for a change in the stock abbreviation in accordance with relevant regulations.

TIME INTERCON (01729) will issue 30,000 shares according to the stock incentive plan on November 26th.

VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.

TIME INTERCON (01729) will issue 30,000 shares according to the stock incentive plan on November 26th.

VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.